The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...

XEC has become the second most prevalent strain in the country, according to data released by the U.S. Centers for Disease Control and Prevention ( CDC ), representing more than 1 in 10 cases. But ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

Polio is once again spreading in Pakistan, where officials say more than 1 million children missed their vaccination doses ...

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV -- ...

The influenza (flu) virus affects millions of Americans each fall, winter and early spring, causing doctor visits, ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

The Winnipeg Regional Health Authority (WRHA) is teaming up with Thrive Community Support Circle to help make vaccinations ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...

The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...